Systemic Endothelial Activation Is Associated With Early Acute Respiratory Distress Syndrome in Children With Extrapulmonary Sepsis.
Adolescent
Biomarkers
Blood Proteins
/ metabolism
Cell Adhesion Molecules
/ metabolism
Child
Child, Preschool
Endothelium
/ physiopathology
Female
Hospital Mortality
Humans
Infant
Inflammation Mediators
Intensive Care Units, Pediatric
/ statistics & numerical data
Longitudinal Studies
Male
Organ Dysfunction Scores
Prognosis
Respiratory Distress Syndrome
/ blood
Sepsis
/ blood
Time Factors
Journal
Critical care medicine
ISSN: 1530-0293
Titre abrégé: Crit Care Med
Pays: United States
ID NLM: 0355501
Informations de publication
Date de publication:
03 2020
03 2020
Historique:
entrez:
15
2
2020
pubmed:
15
2
2020
medline:
24
10
2020
Statut:
ppublish
Résumé
Systemic endothelial activation may contribute to sepsis-associated organ injury, including acute respiratory distress syndrome. We hypothesized that children with extrapulmonary sepsis with versus without acute respiratory distress syndrome would have plasma biomarkers indicative of increased endothelial activation and that persistent biomarker changes would be associated with poor outcome. Observational cohort. Academic PICU. Patients less than 18 years old with sepsis from extrapulmonary infection with (n = 46) or without (n = 54) acute respiratory distress syndrome and noninfected controls (n = 19). None. Endothelial (angiopoietin-1, angiopoietin-2, tyrosine kinase with immunoglobulin-like loop epidermal growth factor homology domain 2, vascular endothelial growth factor, soluble fms-like tyrosine kinase, von Willebrand factor, E-selectin, intercellular adhesion molecule, vascular cell adhesion molecule, thrombomodulin) and inflammatory biomarkers (C-reactive protein, interleukin-6, and interleukin-8) were measured from peripheral plasma collected within 3 days (time 1) of sepsis recognition and at 3-6 days (time 2) and 7-14 days (time 3). Time 1 biomarkers and longitudinal measurements were compared for sepsis patients with versus without acute respiratory distress syndrome and in relation to complicated course, defined as greater than or equal to two organ dysfunctions at day 7 or death by day 28. Angiopoietin-2, angiopoietin-2/angiopoietin-1 ratio, tyrosine kinase with immunoglobulin-like loop epidermal growth factor homology domain 2, vascular endothelial growth factor, von Willebrand factor, E-selectin, intercellular adhesion molecule, vascular cell adhesion molecule, thrombomodulin, endocan, C-reactive protein, interleukin-6, and interleukin-8 were different between sepsis and noninfected control patients at time 1. Among patients with sepsis, those with acute respiratory distress syndrome had higher angiopoietin-2/angiopoietin-1 ratio, vascular endothelial growth factor, vascular cell adhesion molecule, thrombomodulin, endocan, interleukin-6, and interleukin-8 than those without acute respiratory distress syndrome (all p < 0.003). Angiopoietin-2 and angiopoietin-2/angiopoietin-1 ratio remained higher in sepsis with versus without acute respiratory distress syndrome after multivariable analyses. Time 1 measures of angiopoietin-2, angiopoietin-2/-1 ratio, von Willebrand factor, and endocan were indicative of complicated course in all sepsis patients (all area under the receiver operating curve ≥ 0.80). In sepsis without acute respiratory distress syndrome, soluble fms-like tyrosine kinase decreased more quickly and von Willebrand factor and thrombomodulin decreased more slowly in those with complicated course. Children with extrapulmonary sepsis with acute respiratory distress syndrome had plasma biomarkers indicative of greater systemic endothelial activation than those without acute respiratory distress syndrome. Several endothelial biomarkers measured near sepsis recognition were associated with complicated course, whereas longitudinal biomarker changes yielded prognostic information only in those without sepsis-associated acute respiratory distress syndrome.
Identifiants
pubmed: 32058372
doi: 10.1097/CCM.0000000000004091
pii: 00003246-202003000-00008
pmc: PMC8749338
mid: NIHMS1764831
doi:
Substances chimiques
Biomarkers
0
Blood Proteins
0
Cell Adhesion Molecules
0
Inflammation Mediators
0
Types de publication
Journal Article
Observational Study
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
344-352Subventions
Organisme : NICHD NIH HHS
ID : K12 HD047349
Pays : United States
Organisme : NIGMS NIH HHS
ID : K23 GM110496
Pays : United States
Organisme : NHLBI NIH HHS
ID : L30 HL149099
Pays : United States
Commentaires et corrections
Type : CommentIn
Références
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
BMC Infect Dis. 2010 May 28;10:143
pubmed: 20509945
Intensive Care Med. 2015 Mar;41(3):470-8
pubmed: 25643902
Crit Care Med. 2012 Dec;40(12):3238-45
pubmed: 22990455
J Clin Lab Anal. 2016 Nov;30(6):1037-1043
pubmed: 27184083
Crit Care. 2015 Oct 14;19:367
pubmed: 26463042
Shock. 2007 Dec;28(6):650-654
pubmed: 18092380
Microvasc Res. 2014 May;93:92-7
pubmed: 24769132
Shock. 2011 Aug;36(2):104-8
pubmed: 21522043
PLoS One. 2017 Aug 3;12(8):e0182324
pubmed: 28771554
N Engl J Med. 2000 May 4;342(18):1301-8
pubmed: 10793162
J Exp Med. 2006 Jun 12;203(6):1447-58
pubmed: 16702604
Shock. 2008 Apr;29(4):452-7
pubmed: 18598002
Am J Physiol Lung Cell Mol Physiol. 2016 Jun 1;310(11):L1177-84
pubmed: 27130528
Am J Respir Crit Care Med. 2015 May 15;191(10):1147-57
pubmed: 25734408
Pediatr Crit Care Med. 2015 Jun;16(5):428-39
pubmed: 25647235
Science. 1997 Jul 4;277(5322):55-60
pubmed: 9204896
Crit Care Med. 2010 Sep;38(9):1845-51
pubmed: 20581666
Crit Care Med. 2000 Jul;28(7):2600-7
pubmed: 10921602
Cytokine. 2016 Dec;88:267-273
pubmed: 27701021
Am J Respir Crit Care Med. 2005 May 1;171(9):995-1001
pubmed: 15618461
Crit Care Med. 1996 May;24(5):743-52
pubmed: 8706448
J Clin Invest. 1987 Jan;79(1):117-23
pubmed: 3491837
Minerva Anestesiol. 2006 Jan-Feb;72(1-2):69-80
pubmed: 16407808
Crit Care Med. 1998 May;26(5):933-8
pubmed: 9590325
PLoS Med. 2006 Mar;3(3):e46
pubmed: 16417407
Crit Care Med. 2011 Apr;39(4):702-10
pubmed: 21242795
Crit Care. 2017 Feb 9;21(1):25
pubmed: 28179016
Clin Appl Thromb Hemost. 2015 Jul;21(5):469-74
pubmed: 24203354
Thorax. 2008 Oct;63(10):903-9
pubmed: 18559364
Pediatr Pulmonol. 2017 Jan;52(1):91-97
pubmed: 27362747
Dis Markers. 2017;2017:6758721
pubmed: 28947844
Intensive Care Med. 2018 Aug;44(8):1230-1239
pubmed: 29971591
J Crit Care. 2016 Feb;31(1):68-75
pubmed: 26489483
Pediatr Emerg Care. 2020 Dec;36(12):e715-e719
pubmed: 30335688
Crit Care. 2010;14(3):R91
pubmed: 20492647
Indian J Pharmacol. 2014 Nov-Dec;46(6):579-83
pubmed: 25538326
In Vivo. 2015 Mar-Apr;29(2):305-8
pubmed: 25792662
JAMA. 2012 Jun 20;307(23):2526-33
pubmed: 22797452
Pediatr Crit Care Med. 2005 Jan;6(1):2-8
pubmed: 15636651
J Clin Invest. 1990 Aug;86(2):474-80
pubmed: 2384595
Am J Infect Control. 2008 Jun;36(5):309-32
pubmed: 18538699
Am J Respir Crit Care Med. 2017 May 1;195(9):1253-1263
pubmed: 28459336
Intensive Care Med. 2016 Jul;42(7):1137-45
pubmed: 27101828
Clin Chim Acta. 2018 Aug;483:275-280
pubmed: 29750963
Ann Intensive Care. 2017 Sep 7;7(1):93
pubmed: 28884313
Intensive Care Med. 2009 Aug;35(8):1428-37
pubmed: 19533092
PLoS One. 2014 Sep 25;9(9):e108461
pubmed: 25255212
Am J Physiol Lung Cell Mol Physiol. 2016 Feb 1;310(3):L224-31
pubmed: 26660787
Intensive Care Med. 2009 Sep;35(9):1567-74
pubmed: 19551369
Am J Respir Crit Care Med. 2015 Feb 1;191(3):309-15
pubmed: 25489881
Crit Care Med. 2019 Oct;47(10):1433-1441
pubmed: 31385882
Int J Med Sci. 2019 Jan 1;16(2):318-323
pubmed: 30745813
Arch Intern Med. 2007 Aug 13-27;167(15):1655-63
pubmed: 17698689
Pediatr Crit Care Med. 2014 Nov;15(9):798-805
pubmed: 25162514
Shock. 2005 Dec;24(6):508-12
pubmed: 16317379
Blood. 2014 Apr 3;123(14):2153-6
pubmed: 24458436